The Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium is collaborating on epidemiologic studies to address the high burden of prostate cancer among this population. These investigators are interested in understanding the complex multifactorial causes of prostate cancer etiology and outcomes among men of African ancestry worldwide.
Formed in 2007, the consortium includes investigators from the United States, United Kingdom, Africa, and the Caribbean, who have cohort or case-control studies on prostate cancer among men of African ancestry. The investigators share common interests in studying health disparities, underserved populations, and the role that genetic and non-genetic factors play in the disparities. MADCaP collaborative research is intended to improve prostate cancer prevention, detection, and treatment in men of the African diaspora. One important aim is to validate and extend findings on genomic regions that have been associated with prostate cancer risk in genome-wide association studies (GWAS) using a large sample of participants from the studies of consortium members. Participation in the MADCaP Consortium is open to all investigators who have appropriate studies and biospecimens.
THE GOAL OF MADCAP IS TO UNDERTAKE RESEARCH THAT IS:
Able to inform science and clinical practice globally.
Able to inform public health and policy needs locally.
Led by local researchers involved in global collaborative teams.
Timothy R. Rebbeck, PhD.
Principal Investigator, MADCaP Network
Harvard TH Chan School of Public Health and Dana Farber Cancer Institute.
1101 Dana. 450 Brookline Ave. Boston, MA 02215.
Caroline Andrews, MSc
Sr. Research Project Manager
Damali Martin, Ph.D., M.P.H.
Program Director, Genomic Epidemiology Branch
Epidemiology and Genomics Research Program
MADCaP Administrative Team at Dana-Farber Cancer Institute:
At the National Cancer Institute: